Ann Meeker-O’Connell

Ann Meeker-O’Connell has more than 20 years of experience in biomedical research and development in government, academic, and industry settings, including current and prior FDA service in clinical policy and clinical trial compliance.  Over the past decade, she has been engaged in multiple cross-stakeholder initiatives, such as the Clinical Trials Transformation Initiative Quality by Design project, focused on the quality of trial design and streamlining trial delivery to expedite delivery of safe and effective medical products to patients in need.  She received an M.S. in Pharmacology and was an NIH Integrated Toxicology Fellow at Duke University.